glp-1 problems and Shortness of Breath: Causes and When to Seek Care GLP-1s are changing more than

Ozempic is a type of medication called a glucagon-like peptide-1 agonist (GLP-1) and is only given by injection

Documentation of ezetimibe trial (unless contraindicated) at 10 mg daily for 90 days

doi: 10.1161/CIRCULATIONAHA.125.074545 Summary Keywords cardiovascular outcomes, SGLT2 inhibitors, GLP-1 agonists, combination therapy, heart failure, renal outcomes Citation Aristizbal-Colorado D, Corredor-Rengifo D, Sierra-Castillo S, Lpez-Corredor C, Vernaza-Trujillo D-A, Weir-Restrepo D, Izquierdo-Condoy JS, Ortiz-Prado E, Rico-Fontalvo J, Gmez-Mesa J-E, Abreu-Lomba A and Rivera-Martnez W-A (2025) A decade of progress in type 2 diabetes and cardiovascular disease: advances in SGLT2 inhibitors and GLP-1 receptor agonists a comprehensive review

Why users love it: Its fast, intuitive, and does one thing very well